JPRN-jRCT2080222244未知2 期
Phase-IIa Study of AJM300 in Patients with Active Ulcerative Colitis
Ajinomoto Pharmaceuticals Co., Ltd.0 个研究点开始时间: 2013年10月3日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 64age old（—）
- 性别
- All
入选标准
- •Patients with active-phase ulcerative colitis
- •- The Mayo score of 6 to 10.
- •- Mucosal appearance subscore of 2 or more, and Rectal bleeding subscore of 1 or more
- •- Inadequate response to or intolerance of appropriate conventional therapy
排除标准
- 未提供
研究者
相似试验
未知
2 期
Phase-IIa Study of AJM300 in Patients with Active Ulcerative ColitisJPRN-jRCT2080220894Ajinomoto Pharmaceuticals Co., Ltd.
已完成
3 期
Phase III study of AJM300 in patients with active ulcerative colitis (2)Active Ulcerative ColitisJPRN-jRCT2080223867EA Pharma Co., Ltd.198
未知
3 期
Phase III study of AJG511 in patients with active ulcerative colitisulcerative colitisJPRN-jRCT2080222653EA Pharma Co.,Ltd.120
未知
2 期
Phase-II study of AJA777 in patients with functional dyspepsiaFunctional dyspepsia (recruited according to the ROME III criteria)JPRN-jRCT2080221822Ajinomoto Pharmaceuticals Co., Ltd.
未知
2 期
Phase-IIa study of AJA777 in patients with functional dyspepsiaFunctional dyspepsia (recruited according to the ROME III criteria)JPRN-jRCT2080221048Ajinomoto Pharmaceuticals Co., Ltd.